Astera Labs, Inc. (NASDAQ:ALAB) Receives $187.06 Average PT from Brokerages

Astera Labs, Inc. (NASDAQ:ALAB) has been given a consensus recommendation of “Moderate Buy” by the twenty-four research firms that are covering the stock, Marketbeat.com reports. Eight analysts have rated the stock with a hold recommendation, fifteen have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $188.1667.

Several equities analysts recently commented on the company. Jefferies Financial Group restated a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Bank of America started coverage on Astera Labs in a report on Friday, October 3rd. They issued a “neutral” rating and a $230.00 target price on the stock. Morgan Stanley reissued an “overweight” rating and issued a $210.00 price objective on shares of Astera Labs in a report on Wednesday, December 3rd. Raymond James Financial initiated coverage on shares of Astera Labs in a research report on Friday, November 21st. They issued a “hold” rating on the stock. Finally, Stifel Nicolaus increased their price target on shares of Astera Labs from $185.00 to $200.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th.

Insider Activity at Astera Labs

In other news, CFO Michael Truett Tate sold 11,430 shares of Astera Labs stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $1,653,806.70. Following the sale, the chief financial officer directly owned 192,297 shares of the company’s stock, valued at approximately $27,823,452.93. The trade was a 5.61% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jitendra Mohan sold 90,459 shares of the stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the sale, the chief executive officer directly owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. This represents a 4.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 586,936 shares of company stock valued at $89,331,140 over the last quarter. 12.50% of the stock is owned by insiders.

Institutional Trading of Astera Labs

Large investors have recently bought and sold shares of the stock. Value Aligned Research Advisors LLC grew its position in shares of Astera Labs by 16.7% in the 3rd quarter. Value Aligned Research Advisors LLC now owns 1,378,351 shares of the company’s stock valued at $269,881,000 after purchasing an additional 197,320 shares during the period. Allworth Financial LP grew its holdings in Astera Labs by 16.3% in the third quarter. Allworth Financial LP now owns 3,038 shares of the company’s stock worth $595,000 after purchasing an additional 426 shares during the period. IFP Advisors Inc lifted its position in shares of Astera Labs by 11.2% during the third quarter. IFP Advisors Inc now owns 4,599 shares of the company’s stock valued at $900,000 after purchasing an additional 464 shares in the last quarter. Swiss Life Asset Management Ltd boosted its position in Astera Labs by 78.8% during the third quarter. Swiss Life Asset Management Ltd now owns 6,052 shares of the company’s stock worth $1,185,000 after purchasing an additional 2,668 shares during the period. Finally, Polar Asset Management Partners Inc. bought a new position in shares of Astera Labs in the third quarter worth $349,000. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Stock Down 14.3%

Shares of ALAB opened at $148.85 on Friday. The firm has a market cap of $25.14 billion, a price-to-earnings ratio of 134.10, a PEG ratio of 3.24 and a beta of 1.51. Astera Labs has a 52-week low of $47.13 and a 52-week high of $262.90. The business’s 50 day moving average is $166.62 and its two-hundred day moving average is $153.22.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.10. The business had revenue of $230.58 million for the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The business’s revenue was up 103.9% on a year-over-year basis. During the same quarter last year, the business posted $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities analysts expect that Astera Labs will post 0.34 earnings per share for the current fiscal year.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.